Related references
Note: Only part of the references are listed.HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis
Corinne Barat et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
K Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2006)
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
F Pasquau et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
R López-Vélez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Visceral leishmaniasis in those infected with HIV:: clinical aspects and other opportunistic infections
R Russo et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Leishmania/HIV co-infection in Brazil:: an appraisal
A Rabello et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV
R López-Vélez
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Leishmania/HIV co-infections:: epidemiology in Europe
P Desjeux et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients
MJF Cotarelo et al.
CLINICAL INFECTIOUS DISEASES (2003)
Visceral leishmaniasis and HIV in Tigray, Ethiopia
S Lyons et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2003)
Emerging Leishmania/HIV co-infection in Africa
D Wolday et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2001)
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome
K Ritmeijer et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
HIV-associated visceral leishmaniasis
V Pintado et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
The increase in risk factors for leishmaniasis worldwide
P Desjeux
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients - A comparative study
V Pintado et al.
MEDICINE (2001)
Discontinuation of secondary anti-Leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy
J Berenguer et al.
AIDS (2000)
Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
V Soriano et al.
AIDS (2000)